These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32064586)

  • 1. Cortical excitability measured with transcranial magnetic stimulation in children with epilepsy before and after antiepileptic drugs.
    Andreasson AC; Sigurdsson GV; Pegenius G; Thordstein M; Hallböök T
    Dev Med Child Neurol; 2020 Jul; 62(7):793-798. PubMed ID: 32064586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical excitability in epilepsy and the impact of antiepileptic drugs: transcranial magnetic stimulation applications.
    Hamed SA
    Expert Rev Neurother; 2020 Jul; 20(7):707-723. PubMed ID: 32510285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and paired pulse transcranial magnetic stimulation in drug naïve epilepsy.
    de Goede AA; Ter Braack EM; van Putten MJAM
    Clin Neurophysiol; 2016 Sep; 127(9):3140-3155. PubMed ID: 27472551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting seizure control: cortical excitability and antiepileptic medication.
    Badawy RA; Macdonell RA; Berkovic SF; Newton MR; Jackson GD
    Ann Neurol; 2010 Jan; 67(1):64-73. PubMed ID: 20186859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical excitability in cryptogenic localization-related epilepsy: interictal transcranial magnetic stimulation studies.
    Cantello R; Civardi C; Cavalli A; Varrasi C; Tarletti R; Monaco F; Migliaretti G
    Epilepsia; 2000 Jun; 41(6):694-704. PubMed ID: 10840401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy.
    Helling RM; Shmuely S; Bauer PR; Tolner EA; Visser GH; Thijs RD
    Ann Clin Transl Neurol; 2022 Apr; 9(4):540-551. PubMed ID: 35297209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal response of motor cortex to photic stimulation in idiopathic generalized epilepsy.
    Groppa S; Siebner HR; Kurth C; Stephani U; Siniatchkin M
    Epilepsia; 2008 Dec; 49(12):2022-9. PubMed ID: 18627417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.
    Premoli I; Rossini PG; Goldberg PY; Posadas K; Green L; Yogo N; Pimstone S; Abela E; Beatch GN; Richardson MP
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2164-2174. PubMed ID: 31568714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of motor cortex inhibition differentiates between generalized and focal epilepsy.
    Klimpe S; Behrang-Nia M; Bott MC; Werhahn KJ
    Epilepsy Res; 2009 Apr; 84(2-3):210-6. PubMed ID: 19286351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a single dose of retigabine in cortical excitability parameters: A cross-over, double-blind placebo-controlled TMS study.
    Ossemann M; de Fays K; Bihin B; Vandermeeren Y
    Epilepsy Res; 2016 Oct; 126():78-82. PubMed ID: 27448328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peri-ictal state: cortical excitability changes within 24 h of a seizure.
    Badawy R; Macdonell R; Jackson G; Berkovic S
    Brain; 2009 Apr; 132(Pt 4):1013-21. PubMed ID: 19251759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study.
    Menzler K; Hermsen A; Balkenhol K; Duddek C; Bugiel H; Bauer S; Schorge S; Reif PS; Klein KM; Haag A; Oertel WH; Hamer HM; Knake S; Trucks H; Sander T; Rosenow F;
    Epilepsia; 2014 Feb; 55(2):362-9. PubMed ID: 24417206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cortical excitability differentiate generalized and focal epilepsy.
    Badawy RA; Curatolo JM; Newton M; Berkovic SF; Macdonell RA
    Ann Neurol; 2007 Apr; 61(4):324-31. PubMed ID: 17358004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capturing the epileptic trait: cortical excitability measures in patients and their unaffected siblings.
    Badawy RA; Vogrin SJ; Lai A; Cook MJ
    Brain; 2013 Apr; 136(Pt 4):1177-91. PubMed ID: 23485850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of valproate on silent period and corticomotor excitability.
    Kazis DA; Kimiskidis VK; Papagiannopoulos S; Sotirakoglou K; Divanoglou D; Vlaikidis N; Mills KR; Kazis A
    Epileptic Disord; 2006 Jun; 8(2):136-42. PubMed ID: 16793575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread inter-ictal excitability changes in patients with temporal lobe epilepsy: A TMS/MEG study.
    Hsu WY; Kuo YF; Liao KK; Yu HY; Lin YY
    Epilepsy Res; 2015 Mar; 111():61-71. PubMed ID: 25769374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting motor threshold in idiopathic generalized epilepsies: a systematic review with meta-analysis.
    Brigo F; Storti M; Benedetti MD; Rossini F; Nardone R; Tezzon F; Fiaschi A; Bongiovanni LG; Manganotti P
    Epilepsy Res; 2012 Aug; 101(1-2):3-13. PubMed ID: 22542570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs).
    Bolden LB; Griffis JC; Nenert R; Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2019 Jan; 90():84-89. PubMed ID: 30517908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical excitability in drug naive juvenile myoclonic epilepsy.
    Puri V; Sajan PM; Chowdhury V; Chaudhry N
    Seizure; 2013 Oct; 22(8):662-9. PubMed ID: 23746624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Epilepsy and Antiepileptic Drugs on Cortical Motor Excitability in Patients With Temporal Lobe Epilepsy.
    Hamed SA; Tohamy AM; Mohamed KO; El Mageed Abd El Zaher MA
    Clin Neuropharmacol; 2020; 43(6):175-184. PubMed ID: 32969972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.